Aura Biosciences Inc
Ownership
Ownership Structure
Who owns Aura Biosciences Inc (AURA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 76.8% of the shares are freely tradable; institutional investors hold 51.0%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| TCG Crossover Management, LLC | 9.21 | 9,533,333 | +0.0 | 06/30/2026 |
| Matrix Capital Management Company, LLC | 6.69 | 6,922,870 | +0.0 | 03/31/2026 |
| Long Focus Capital Management, LLC | 4.95 | 5,119,582 | +10.8 | 06/30/2026 |
| Frazier Life Sciences Management, L.P. | 4.93 | 5,100,000 | +0.0 | 03/31/2026 |
| Adage Capital Partners Gp LLC | 4.48 | 4,640,000 | -4.9 | 06/30/2026 |
| Suvretta Capital Management, LLC | 4.23 | 4,372,884 | +0.0 | 03/31/2026 |
| Caligan Partners LP | 4.15 | 4,298,248 | +1,769.9 | 06/30/2026 |
| BlackRock Inc | 3.47 | 3,586,640 | +0.7 | 03/31/2026 |
| Medicxi Ventures Management (Jersey) Ltd | 2.94 | 3,039,892 | +0.0 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 2.86 | 2,959,422 | +2.0 | 07/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Hopkins Janet Jill | Chief Medical Officer | 380,190 | 2,433,216 $ | Sep 1, 2026 | direct |
| Elazzouzi Amy | SVP, Finance & PAO | 143,600 | 919,040 $ | Sep 1, 2026 | direct |
| Abu-Absi Susan | Chief Operating Officer | 134,513 | 860,883 $ | Sep 1, 2026 | direct |
| Person Julie | Chief People Officer | 107,611 | 688,710 $ | Sep 1, 2026 | direct |
| Kratz Erica | Chief Reg. & Quality Officer | 100,885 | 645,664 $ | Sep 1, 2026 | direct |
| Bender Jeremy | Director | 30,000 | 192,000 $ | Jul 7, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | Kratz Erica | Chief Reg. & Quality Officer | Other | 100,885 | 0.00 | – |
| Sep 1, 2026 | Abu-Absi Susan | Chief Operating Officer | Other | 134,513 | 0.00 | – |
| Sep 1, 2026 | Elazzouzi Amy | SVP, Finance & PAO | Other | 23,540 | 0.00 | – |
| Sep 1, 2026 | Hopkins Janet Jill | Chief Medical Officer | Other | 58,850 | 0.00 | – |
| Sep 1, 2026 | Person Julie | Chief People Officer | Other | 107,611 | 0.00 | – |
| Jul 7, 2026 | Bender Jeremy | Director | Other | 30,000 | 0.00 | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.